{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:34:21Z","timestamp":1791534861919,"version":"4.3.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer. Many medications that had been used for a long period to treat the illness were eventually stopped due to negative effects or the development of drug resistance in HCC patients. Canagliflozin (CANA), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, showed in vitro anti-carcinogenic efficacy against various cancer models\u2019 other livers. The current study used rat models to examine canagliflozin\u2019s therapeutic role against experimentally induced HCC. A total of 32 rats were divided into four groups, eight in each: negative control; HCC control: rats were fed a choline-deficient diet (CDD) and subjected to diethyl nitrosamine and thioacetamide (DEN\/TAA) injections for 15\u00a0weeks; and treated groups: rats were given CANA (10 and 20\u00a0mg\/kg b.wt.) orally from the 7th week of the experiment till the end. All the measured markers of HCC, liver function, and inflammatory markers were elevated in the HCC control group compared to the negative control (CTRL). Regarding immunohistochemistry, the HCC group showed downregulation in caspase-3 expression and upregulation in PCNA expression. On the other hand, canagliflozin-treated groups showed dose-dependent improvement in the measured parameters associated with HCC. Moreover, canagliflozin therapy ameliorates the histopathological alterations in HCC-induced rats. Taken together, CANA exhibits anti-HCC effects by activating AMP-activated protein kinase (AMPK) and suppressing the HIF-1\u03b1\/YAP\/TAZ pathway, making it a forthcoming therapeutic option for HCC.<\/jats:p>","DOI":"10.1007\/s00210-025-04098-8","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T06:24:59Z","timestamp":1748499899000},"page":"16131-16148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD\/DEN\/TAA in a rat model: regulation of AMPK\/HIF-1\u03b1\/YAP-1\/TAZ signaling pathways"],"prefix":"10.1007","volume":"398","author":[{"given":"Hany M.","family":"Fayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gihan F.","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marawan A.","family":"Elbaset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola A.","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan S.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab A.","family":"El-Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherein S.","family":"Abdelgayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab F.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"12","key":"4098_CR1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/term.2940","volume":"13","author":"SS Abd El-Rahman","year":"2019","unstructured":"Abd El-Rahman SS, Fayed HM (2019) Targeting AngII\/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat. J Tissue Eng Regen Med 13(12):2131\u20132141","journal-title":"J Tissue Eng Regen Med"},{"issue":"1","key":"4098_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/ejhm.2004.18171","volume":"16","author":"IZ Abdallah","year":"2004","unstructured":"Abdallah IZ, Khattab HA (2004) Protective role of lycopene against diethylnitrosamine induced experimental hepatocarcinogenesis. The Egyptian Journal of Hospital Medicine 16(1):1\u201313","journal-title":"The Egyptian Journal of Hospital Medicine"},{"issue":"4","key":"4098_CR3","doi-asserted-by":"crossref","first-page":"e202100960","DOI":"10.1002\/cbdv.202100960","volume":"19","author":"RF Abdel-Rahman","year":"2022","unstructured":"Abdel-Rahman RF, Fayed HM, Ogaly HA, Hussein RA, Raslan MA (2022) Phytoconstituents of Sansevieria suffruticosa N.E.Br. leaves and its hepatoprotective effect via activation of the NRF2\/ARE signaling pathway in an experimentally induced liver fibrosis rat model. Chem Biodivers 19(4):e202100960","journal-title":"Chem Biodivers"},{"key":"4098_CR4","volume":"2","author":"RF Abdel-Rahman","year":"2024","unstructured":"Abdel-Rahman RF, Elbaset MA, Fayed HM, Esatbeyoglu T, Afifi SM, Diab RA (2024) Reno-protective effect of Roflumilast against kidney injury induced by ischemia\/reperfusion in rats: evidence from biochemical and histological investigations. Pharmacol Res - Rep 2:100014","journal-title":"Pharmacol Res - Rep"},{"issue":"2","key":"4098_CR5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3892\/ol.2015.3313","volume":"10","author":"W Abdo","year":"2015","unstructured":"Abdo W, Hirata A, Shukry M, Kamal T, Abdel-Sattar E, Mahrous E et al (2015) Calligonum comosum extract inhibits diethylnitrosamine-induced hepatocarcinogenesis in rats. Oncol Lett 10(2):716\u2013722","journal-title":"Oncol Lett"},{"key":"4098_CR6","unstructured":"Afifi N, Yassin N, Fawzy R, Rahman A, Aiad A, Afifi N, et al (2014) Fayed. Hepatoprotective effect of artichoke extract against pre-cancerous lesion of experimentally induced hepatocellular carcinoma in rats 1097\u20138135"},{"issue":"1","key":"4098_CR7","first-page":"1","volume":"4","author":"S Arsad","year":"2014","unstructured":"Arsad S, Esa N, Hamzah H (2014) Histopathologic changes in liver and kidney tissues from male Sprague Dawley rats treated with Rhaphidophora decursiva (Roxb.) Schott extract. J Cytol Histol S 4(1):1\u20136","journal-title":"J Cytol Histol S"},{"issue":"19","key":"4098_CR8","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.3390\/molecules27196470","volume":"27","author":"IM Ayoub","year":"2022","unstructured":"Ayoub IM, El-Baset MA, Elghonemy MM, Bashandy SAE, Ibrahim FAA, Ahmed-Farid OAH et al (2022) Chemical profile of Cyperus laevigatus and its protective effects against thioacetamide-induced hepatorenal toxicity in rats. Molecules 27(19):6470","journal-title":"Molecules"},{"key":"4098_CR9","unstructured":"Bancroft JD, Gamble M (2008) Theory and practice of histological techniques: Elsevier health sciences"},{"issue":"3","key":"4098_CR10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00244-010-9494-5","volume":"59","author":"M Banni","year":"2010","unstructured":"Banni M, Messaoudi I, Said L, El Heni J, Kerkeni A, Said K (2010) Metallothionein gene expression in liver of rats exposed to cadmium and supplemented with zinc and selenium. Arch Environ Contam Toxicol 59(3):513\u2013519","journal-title":"Arch Environ Contam Toxicol"},{"key":"4098_CR11","doi-asserted-by":"publisher","unstructured":"Basak D, Gamez D, Deb S (2023) SGLT2 inhibitors as potential anticancer agents. Biomedicines 11(7);1867. https:\/\/doi.org\/10.3390\/biomedicines11071867","DOI":"10.3390\/biomedicines11071867"},{"issue":"11","key":"4098_CR12","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1878-0261.13508","volume":"17","author":"OD Biziotis","year":"2023","unstructured":"Biziotis OD, Tsakiridis EE, Ali A, Ahmadi E, Wu J, Wang S et al (2023) Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1\u03b1. Mol Oncol 17(11):2235\u20132256","journal-title":"Mol Oncol"},{"issue":"21","key":"4098_CR13","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1101\/gad.1978810","volume":"24","author":"J Cai","year":"2010","unstructured":"Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24(21):2383\u20132388","journal-title":"Genes Dev"},{"issue":"1","key":"4098_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bjc.2013.285","volume":"109","author":"S Carbajo-Pescador","year":"2013","unstructured":"Carbajo-Pescador S, Ordo\u00f1ez R, Benet M, Jover R, Garc\u00eda-Palomo A, Mauriz JL et al (2013) Inhibition of VEGF expression through blockade of Hif1\u03b1 and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer 109(1):83\u201391","journal-title":"Br J Cancer"},{"issue":"1","key":"4098_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/diaclin.32.1.4","volume":"32","author":"EC Chao","year":"2014","unstructured":"Chao EC (2014) SGLT-2 inhibitors: a new mechanism for glycemic control. Clin Diabetes 32(1):4\u201311","journal-title":"Clin Diabetes"},{"key":"4098_CR16","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1245\/s10434-011-2159-4","volume":"19","author":"H-C Chen","year":"2012","unstructured":"Chen H-C, Jeng Y-M, Yuan R-H, Hsu H-C, Chen Y-L (2012) SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis. Ann Surg Oncol 19:2011\u20132019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4098_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3892\/ol.2020.11635","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, He M, Chen J, Li C, Zhang Q (2020) Long non-coding RNA SNHG7 inhibits NLRP3-dependent pyroptosis by targeting the miR-34a\/SIRT1 axis in liver cancer. Oncol Lett 20(1):893\u2013901","journal-title":"Oncol Lett"},{"issue":"4","key":"4098_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/00325481.2019.1601404","volume":"131","author":"JA Davidson","year":"2019","unstructured":"Davidson JA (2019) SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence. Postgrad Med 131(4):251\u2013260","journal-title":"Postgrad Med"},{"issue":"6","key":"4098_CR19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2008.07.024","volume":"49","author":"VM de Lima","year":"2008","unstructured":"de Lima VM, Oliveira CP, Alves VA, Chammas MC, Oliveira EP, Stefano JT et al (2008) A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol 49(6):1055\u20131061","journal-title":"J Hepatol"},{"issue":"1","key":"4098_CR20","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ et al (2015) Type 2 diabetes mellitus. Nat Rev Dis Primers 1(1):15019","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4098_CR21","volume":"8","author":"B Deng","year":"2013","unstructured":"Deng B, Zhu JM, Wang Y, Liu TT, Ding YB, Xiao WM et al (2013) Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-\u03b21 in gastric cancer. PLoS ONE 8(5):e63777","journal-title":"PLoS ONE"},{"issue":"12","key":"4098_CR22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","volume":"47","author":"GM DeNicola","year":"2015","unstructured":"DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D et al (2015) NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet 47(12):1475\u20131481","journal-title":"Nat Genet"},{"issue":"2","key":"4098_CR23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.celrep.2014.09.036","volume":"9","author":"M DeRan","year":"2014","unstructured":"DeRan M, Yang J, Shen C-H, Peters Eric C, Fitamant J, Chan P et al (2014) Energy stress regulates Hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep 9(2):495\u2013503","journal-title":"Cell Rep"},{"key":"4098_CR24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2016.10.019","volume":"385","author":"W Duan","year":"2017","unstructured":"Duan W, Chen K, Jiang Z, Chen X, Sun L, Li J et al (2017) Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. Cancer Lett 385:225\u2013233","journal-title":"Cancer Lett"},{"issue":"23","key":"4098_CR25","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.3390\/cancers14235811","volume":"14","author":"M Dutka","year":"2022","unstructured":"Dutka M, Bobi\u0144ski R, Francuz T, Garczorz W, Zimmer K, Ilczak T et al (2022) SGLT-2 inhibitors in cancer treatment-mechanisms of action and emerging new perspectives. Cancers (Basel) 14(23):5811","journal-title":"Cancers (Basel)"},{"key":"4098_CR26","doi-asserted-by":"crossref","first-page":"5514248","DOI":"10.1155\/2023\/5514248","volume":"2023","author":"MA Elbaset","year":"2023","unstructured":"Elbaset MA, Mohamed B, Moustafa PE, Mansour DF, Afifi SM, Esatbeyoglu T et al (2023) Erythropoietin suppresses the hepatic fibrosis caused by thioacetamide: role of the PI3K\/Akt and TLR4 signaling pathways. Oxid Med Cell Longev 2023:5514248","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"4098_CR27","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18116","volume":"28","author":"MA Elbaset","year":"2024","unstructured":"Elbaset MA, Mohamed B, Hessin A, Abd El-Rahman SS, Esatbeyoglu T, Afifi SM et al (2024) Nrf2\/HO-1, NF-\u03baB and PI3K\/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats. J Cell Mol Med 28(3):e18116","journal-title":"J Cell Mol Med"},{"issue":"8","key":"4098_CR28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-024-06955-5","volume":"15","author":"Y Elleithi","year":"2024","unstructured":"Elleithi Y, El-Gayar A, Amin MN (2024) Autophagy modulation attenuates sorafenib resistance in HCC induced in rats. Cell Death Dis 15(8):595","journal-title":"Cell Death Dis"},{"issue":"9","key":"4098_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","volume":"11","author":"A Garten","year":"2015","unstructured":"Garten A, Schuster S, Penke M, Gorski T, De Giorgis T, Kiess W (2015) Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol 11(9):535\u2013546","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4098_CR30","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1038\/s41598-020-71449-1","volume":"10","author":"R Hasan","year":"2020","unstructured":"Hasan R, Lasker S, Hasan A, Zerin F, Zamila M, Chowdhury FI et al (2020) Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways. Sci Rep 10(1):14459","journal-title":"Sci Rep"},{"issue":"1","key":"4098_CR31","doi-asserted-by":"crossref","first-page":"2365590","DOI":"10.1080\/13510002.2024.2365590","volume":"29","author":"HM Hassan","year":"2024","unstructured":"Hassan HM, Hamdan AM, Alattar A, Alshaman R, Bahattab O, Al-Gayyar MMH (2024) Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC\/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats. Redox Rep 29(1):2365590","journal-title":"Redox Rep"},{"issue":"9","key":"4098_CR32","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","volume":"65","author":"SA Hawley","year":"2016","unstructured":"Hawley SA, Ford RJ, Smith BK, Gowans GJ, Mancini SJ, Pitt RD et al (2016) The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels. Diabetes 65(9):2784\u20132794","journal-title":"Diabetes"},{"issue":"4","key":"4098_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","volume":"39","author":"JD Hayes","year":"2014","unstructured":"Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39(4):199\u2013218","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"4098_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","volume":"17","author":"G He","year":"2010","unstructured":"He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T et al (2010) Hepatocyte IKKbeta\/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17(3):286\u2013297","journal-title":"Cancer Cell"},{"issue":"1","key":"4098_CR35","volume":"9","author":"Q He","year":"2014","unstructured":"He Q, Yang QC, Zhou Q, Zhu H, Niu WY, Feng J et al (2014) Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes. PLoS ONE 9(1):e86326","journal-title":"PLoS ONE"},{"issue":"7","key":"4098_CR36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","volume":"23","author":"W Hong","year":"2012","unstructured":"Hong W, Guan KL (2012) The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol 23(7):785\u2013793","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"4098_CR37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41419-019-1646-6","volume":"10","author":"M-H Hung","year":"2019","unstructured":"Hung M-H, Chen Y-L, Chen L-J, Chu P-Y, Hsieh F-S, Tsai M-H et al (2019) Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced \u03b2-catenin activation. Cell Death Dis 10(6):420","journal-title":"Cell Death Dis"},{"issue":"1","key":"4098_CR38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3892\/mmr.2015.4513","volume":"13","author":"W Jo","year":"2016","unstructured":"Jo W, Yu ES, Chang M, Park HK, Choi HJ, Ryu JE et al (2016) Metformin inhibits early stage diethylnitrosamine-induced hepatocarcinogenesis in rats. Mol Med Rep 13(1):146\u2013152","journal-title":"Mol Med Rep"},{"issue":"1","key":"4098_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrd4161","volume":"13","author":"R Johnson","year":"2014","unstructured":"Johnson R, Halder G (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discovery 13(1):63\u201379","journal-title":"Nat Rev Drug Discovery"},{"key":"4098_CR40","doi-asserted-by":"crossref","unstructured":"Jojima T, Wakamatsu S, Kase M, Iijima T, Maejima Y, Shimomura K et al (2019) The SGLT2 inhibitor canagliflozin prevents carcinogenesis in a mouse model of diabetes and non-alcoholic steatohepatitis-related hepatocarcinogenesis: association with SGLT2 expression in hepatocellular carcinoma 20(20)","DOI":"10.3390\/ijms20205237"},{"key":"4098_CR41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2018.03.043","volume":"828","author":"SL Kabil","year":"2018","unstructured":"Kabil SL, Mahmoud NM (2018) Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation. Eur J Pharmacol 828:135\u2013145","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"4098_CR42","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ijc.31193","volume":"142","author":"K Kaji","year":"2018","unstructured":"Kaji K, Nishimura N, Seki K, Sato S, Saikawa S, Nakanishi K et al (2018) Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake. Int J Cancer 142(8):1712\u20131722","journal-title":"Int J Cancer"},{"issue":"1","key":"4098_CR43","first-page":"62","volume":"24","author":"DY Kim","year":"2024","unstructured":"Kim DY (2024) Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide. J Liver Cancer 24(1):62\u201370","journal-title":"J Liver Cancer"},{"issue":"7\u20138","key":"4098_CR44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.etp.2013.01.012","volume":"65","author":"M Kimura","year":"2013","unstructured":"Kimura M, Fujii Y, Yamamoto R, Yafune A, Hayashi SM, Suzuki K et al (2013) Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model. Exp Toxicol Pathol 65(7\u20138):979\u2013988","journal-title":"Exp Toxicol Pathol"},{"issue":"19","key":"4098_CR45","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.3390\/cancers13194981","volume":"13","author":"K Kurma","year":"2021","unstructured":"Kurma K, Manches O, Chuffart F, Sturm N, Gharzeddine K, Zhang J et al (2021) DEN-induced rat model reproduces key features of human hepatocellular carcinoma. Cancers (Basel) 13(19):4981","journal-title":"Cancers (Basel)"},{"issue":"17","key":"4098_CR46","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-12-0429","volume":"72","author":"CW Lee","year":"2012","unstructured":"Lee CW, Wong LL, Tse EY, Liu HF, Leong VY, Lee JM et al (2012) AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res 72(17):4394\u20134404","journal-title":"Cancer Res"},{"issue":"7","key":"4098_CR47","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"QY Lei","year":"2008","unstructured":"Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28(7):2426\u20132436","journal-title":"Mol Cell Biol"},{"issue":"9","key":"4098_CR48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3(9):651\u2013662","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"23","key":"4098_CR49","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1158\/1078-0432.CCR-06-0484","volume":"12","author":"WC Li","year":"2006","unstructured":"Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y et al (2006) Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res 12(23):7140\u20137148","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4098_CR50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.1865810","volume":"24","author":"Z Li","year":"2010","unstructured":"Li Z, Zhao B, Wang P, Chen F, Dong Z, Yang H et al (2010) Structural insights into the YAP and TEAD complex. Genes Dev 24(3):235\u2013240","journal-title":"Genes Dev"},{"issue":"6","key":"4098_CR51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/1878-0261.12067","volume":"11","author":"S Ling","year":"2017","unstructured":"Ling S, Li J, Shan Q, Dai H, Lu D, Wen X et al (2017) USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1\/AKT\/MRP1 signaling pathway. Mol Oncol 11(6):682\u2013695","journal-title":"Mol Oncol"},{"issue":"3","key":"4098_CR52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jcmm.12745","volume":"20","author":"Y Lu","year":"2016","unstructured":"Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y et al (2016) Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med 20(3):549\u2013558","journal-title":"J Cell Mol Med"},{"issue":"24","key":"4098_CR53","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.3390\/ijms222413336","volume":"22","author":"J Luo","year":"2021","unstructured":"Luo J, Sun P, Zhang X, Lin G, Xin Q, Niu Y et al (2021) Canagliflozin modulates hypoxia-induced metastasis, angiogenesis and glycolysis by decreasing HIF-1\u03b1 protein synthesis via AKT\/mTOR pathway. Int J Mol Sci 22(24):13336","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4098_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21608\/amj.2020.67534","volume":"49","author":"N Mabrouk Gabr","year":"2020","unstructured":"Mabrouk Gabr N, Hassan MI (2020) A comparative study of canagliflozin (INVOKANA) on type-I and type-II diabetes mellitus on adult male Albino rat. Al-Azhar Medical Journal 49(1):15\u201332","journal-title":"Al-Azhar Medical Journal"},{"issue":"6","key":"4098_CR55","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2337\/db05-1359","volume":"55","author":"RJ McCrimmon","year":"2006","unstructured":"McCrimmon RJ, Fan X, Cheng H, McNay E, Chan O, Shaw M et al (2006) Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 55(6):1755\u20131760","journal-title":"Diabetes"},{"issue":"4","key":"4098_CR56","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008656","volume":"5","author":"DR McIlwain","year":"2013","unstructured":"McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5(4):a008656","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"4098_CR57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H et al (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22(1):66\u201379","journal-title":"Cancer Cell"},{"issue":"2","key":"4098_CR58","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.18295\/squmj.2016.16.02.002","volume":"16","author":"J Mohamed","year":"2016","unstructured":"Mohamed J, Nazratun Nafizah AH, Zariyantey AH, Budin SB (2016) Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. Sultan Qaboos Univ Med J 16(2):e132\u2013e141","journal-title":"Sultan Qaboos Univ Med J"},{"key":"4098_CR59","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.toxrep.2019.08.007","volume":"6","author":"NZ Mohamed","year":"2019","unstructured":"Mohamed NZ, Aly HF, moneim El-Mezayen HA, El-Salamony HE (2019) Effect of co-administration of bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicol Rep 6:875\u201388","journal-title":"Toxicol Rep"},{"issue":"12","key":"4098_CR60","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/glycob\/cwm094","volume":"17","author":"K Moriwaki","year":"2007","unstructured":"Moriwaki K, Noda K, Nakagawa T, Asahi M, Yoshihara H, Taniguchi N et al (2007) A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation. Glycobiology 17(12):1311\u20131320","journal-title":"Glycobiology"},{"issue":"Pt 1","key":"4098_CR61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.2006.108324","volume":"574","author":"H Motoshima","year":"2006","unstructured":"Motoshima H, Goldstein BJ, Igata M, Araki E (2006) AMPK and cell proliferation\u2013AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 574(Pt 1):63\u201371","journal-title":"J Physiol"},{"key":"4098_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-019-0203-1","volume":"7","author":"AR Nasiri","year":"2019","unstructured":"Nasiri AR, Rodrigues MR, Li Z, Leitner BP, Perry RJ (2019) SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia. Cancer & Metabolism 7:1\u201313","journal-title":"Cancer & Metabolism"},{"issue":"2","key":"4098_CR63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/019262338201000212","volume":"10","author":"PM Newberne","year":"1982","unstructured":"Newberne PM, Camargo JL, Clark AJ (1982) Choline deficiency, partial hepatectomy, and liver tumors in rats and mice. Toxicol Pathol 10(2):95\u2013106","journal-title":"Toxicol Pathol"},{"issue":"4","key":"4098_CR64","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/alcalc\/agh074","volume":"39","author":"H Nyblom","year":"2004","unstructured":"Nyblom H, Berggren U, Balldin J, Olsson R (2004) High AST\/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 39(4):336\u2013339","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"4098_CR65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D (2010) The Hippo signaling pathway in development and cancer. Dev Cell 19(4):491\u2013505","journal-title":"Dev Cell"},{"issue":"3","key":"4098_CR66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","volume":"152","author":"SH Patel","year":"2017","unstructured":"Patel SH, Camargo FD, Yimlamai D (2017) Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis. Gastroenterology 152(3):533\u2013545","journal-title":"Gastroenterology"},{"issue":"2","key":"4098_CR67","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/joim.12016","volume":"273","author":"F Polet","year":"2013","unstructured":"Polet F, Feron O (2013) Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med 273(2):156\u2013165","journal-title":"J Intern Med"},{"issue":"6","key":"4098_CR68","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/1878-0261.12496","volume":"13","author":"Y Qin","year":"2019","unstructured":"Qin Y, Sekine I, Hanazono M, Morinaga T, Fan M, Takiguchi Y et al (2019) AMPK activation induced in pemetrexed-treated cells is associated with development of drug resistance independently of target enzyme expression. Mol Oncol 13(6):1419\u20131432","journal-title":"Mol Oncol"},{"issue":"1","key":"4098_CR69","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/10717544.2019.1606865","volume":"26","author":"M Rahman","year":"2019","unstructured":"Rahman M, Al-Ghamdi SA, Alharbi KS, Beg S, Sharma K, Anwar F et al (2019) Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma. Drug Deliv 26(1):782\u2013793","journal-title":"Drug Deliv"},{"key":"4098_CR70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cbi.2018.05.002","volume":"289","author":"A Ramadan","year":"2018","unstructured":"Ramadan A, Afifi N, Yassin NZ, Abdel-Rahman RF, Abd El-Rahman SS, Fayed HM (2018) Mesalazine, an osteopontin inhibitor: the potential prophylactic and remedial roles in induced liver fibrosis in rats. Chem Biol Interact 289:109\u2013118","journal-title":"Chem Biol Interact"},{"issue":"11","key":"4098_CR71","first-page":"6647","volume":"64","author":"M Raslan","year":"2021","unstructured":"Raslan M, Abdel Rahman R, Fayed H, Ogaly H, Fikry R (2021) Metabolomic profiling of sansevieria trifasciata hort ex. Prain leaves and roots by HPLC-PAD-ESI\/MS and its hepatoprotective effect via activation of the NRF2\/ARE signaling pathway in an experimentally induced liver fibrosis rat model. Egypt J Chem 64(11):6647\u201371","journal-title":"Egypt J Chem"},{"issue":"1\u20132","key":"4098_CR72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2007.09.007","volume":"243","author":"RD Rekha","year":"2008","unstructured":"Rekha RD, Amali AA, Her GM, Yeh YH, Gong HY, Hu SY et al (2008) Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology 243(1\u20132):11\u201322","journal-title":"Toxicology"},{"issue":"49","key":"4098_CR73","doi-asserted-by":"crossref","first-page":"50754","DOI":"10.1074\/jbc.M408388200","volume":"279","author":"JR Revollo","year":"2004","unstructured":"Revollo JR, Grimm AA, Imai S-i (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279(49):50754\u201363","journal-title":"J Biol Chem"},{"issue":"11","key":"4098_CR74","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","volume":"23","author":"R Romero","year":"2017","unstructured":"Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE et al (2017) Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med 23(11):1362\u20131368","journal-title":"Nat Med"},{"issue":"11","key":"4098_CR75","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.18632\/oncotarget.754","volume":"3","author":"B Rotblat","year":"2012","unstructured":"Rotblat B, Melino G, Knight RA (2012) NRF2 and p53: Januses in cancer? Oncotarget 3(11):1272\u20131283","journal-title":"Oncotarget"},{"issue":"7","key":"4098_CR76","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.3390\/ijms23073778","volume":"23","author":"Z Sas","year":"2022","unstructured":"Sas Z, Cendrowicz E, Weinh\u00e4user I, Rygiel TP (2022) Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options. Int J Mol Sci 23(7):3778","journal-title":"Int J Mol Sci"},{"key":"4098_CR77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2016.10.006","volume":"463","author":"C Sauzay","year":"2016","unstructured":"Sauzay C, Petit A, Bourgeois AM, Barbare JC, Chauffert B, Galmiche A et al (2016) Alpha-foetoprotein (AFP): a multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta 463:39\u201344","journal-title":"Clin Chim Acta"},{"issue":"30","key":"4098_CR78","doi-asserted-by":"crossref","first-page":"E4111","DOI":"10.1073\/pnas.1511698112","volume":"112","author":"C Scafoglio","year":"2015","unstructured":"Scafoglio C, Hirayama BA, Kepe V, Liu J, Ghezzi C, Satyamurthy N et al (2015) Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci 112(30):E4111\u2013E4119","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4098_CR79","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41598-018-19658-7","volume":"8","author":"K Shiba","year":"2018","unstructured":"Shiba K, Tsuchiya K, Komiya C, Miyachi Y, Mori K, Shimazu N et al (2018) Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. Sci Rep 8(1):2362","journal-title":"Sci Rep"},{"issue":"13","key":"4098_CR80","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1039\/C7RA12775H","volume":"8","author":"D Singh","year":"2018","unstructured":"Singh D, Singh M, Yadav E, Falls N, Komal U, Dangi DS et al (2018) Amelioration of diethylnitrosamine (DEN)-induced hepatocellular carcinogenesis in animal models via knockdown oxidative stress and proinflammatory markers by Madhuca longifolia embedded silver nanoparticles. RSC Adv 8(13):6940\u20136953","journal-title":"RSC Adv"},{"issue":"4","key":"4098_CR81","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/fcp.12990","volume":"38","author":"YM Tamim","year":"2024","unstructured":"Tamim YM, Nagy AA, Abdellah AM, Osman AH, Ismail AFM (2024) Anticancer effect of propranolol on diethylnitrosamine-induced hepatocellular carcinoma rat model. Fundam Clin Pharmacol 38(4):742\u2013757","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"4098_CR82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ijms22020603","volume":"22","author":"M Tolomeo","year":"2021","unstructured":"Tolomeo M, Cascio A (2021) The multifaced role of STAT3 in cancer and its implication for anticancer therapy. Int J Mol Sci 22(2):603","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4098_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","volume":"160","author":"M Valko","year":"2006","unstructured":"Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1):1\u201340","journal-title":"Chem Biol Interact"},{"issue":"10","key":"4098_CR84","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","volume":"5","author":"LA Villani","year":"2016","unstructured":"Villani LA, Smith BK, Marcinko K, Ford RJ, Broadfield LA, Green AE et al (2016) The diabetes medication canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration. Molecular Metabolism 5(10):1048\u20131056","journal-title":"Molecular Metabolism"},{"issue":"5","key":"4098_CR85","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","volume":"7","author":"H Wang","year":"2011","unstructured":"Wang H, Lafdil F, Kong X, Gao B (2011) Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci 7(5):536\u2013550","journal-title":"Int J Biol Sci"},{"issue":"4","key":"4098_CR86","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncb3113","volume":"17","author":"W Wang","year":"2015","unstructured":"Wang W, Xiao Z-D, Li X, Aziz KE, Gan B, Johnson RL et al (2015) AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol 17(4):490\u2013499","journal-title":"Nat Cell Biol"},{"issue":"8","key":"4098_CR87","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/1389450116666150316223655","volume":"17","author":"Z Wang","year":"2016","unstructured":"Wang Z, Liu P, Chen Q, Deng S, Liu X, Situ H et al (2016) Targeting AMPK signaling pathway to overcome drug resistance for cancer therapy. Curr Drug Targets 17(8):853\u2013864","journal-title":"Curr Drug Targets"},{"issue":"11\u201312","key":"4098_CR88","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000518492","volume":"106","author":"S Wang","year":"2021","unstructured":"Wang S, Ding Y, Dong R, Wang H, Yin L, Meng S (2021) Canagliflozin improves liver function in rats by upregulating asparagine synthetase. Pharmacology 106(11\u201312):606\u2013615","journal-title":"Pharmacology"},{"issue":"4","key":"4098_CR89","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M et al (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375(4):323\u2013334","journal-title":"N Engl J Med"},{"issue":"7","key":"4098_CR90","doi-asserted-by":"crossref","first-page":"12778","DOI":"10.3390\/ijms150712778","volume":"15","author":"W-D Wu","year":"2014","unstructured":"Wu W-D, Hu Z-M, Shang M-J, Zhao D-J, Zhang C-W, Hong D-F et al (2014) Cordycepin down-regulates multiple drug resistant (MDR)\/HIF-1\u03b1 through regulating AMPK\/mTORC1 signaling in GBC-SD gallbladder cancer cells. Int J Mol Sci 15(7):12778\u201312790","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4098_CR91","first-page":"189","volume":"73","author":"AH Wyllie","year":"1997","unstructured":"Wyllie AH (1997) Apoptosis and carcinogenesis. Eur J Cell Biol 73(3):189\u2013197","journal-title":"Eur J Cell Biol"},{"key":"4098_CR92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2020.09.005","volume":"495","author":"Z Xie","year":"2020","unstructured":"Xie Z, Wang F, Lin L, Duan S, Liu X, Li X et al (2020) An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells. Cancer Lett 495:200\u2013210","journal-title":"Cancer Lett"},{"issue":"7","key":"4098_CR93","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3349\/ymj.2022.63.7.619","volume":"63","author":"Z Xu","year":"2022","unstructured":"Xu Z, Hu W, Wang B, Xu T, Wang J, Wei D (2022) Canagliflozin ameliorates nonalcoholic fatty liver disease by regulating lipid metabolism and inhibiting inflammation through induction of autophagy. Yonsei Med J 63(7):619\u2013631","journal-title":"Yonsei Med J"},{"issue":"2","key":"4098_CR94","first-page":"1551","volume":"16","author":"W Yang","year":"2018","unstructured":"Yang W, Luo Y, Hu S, Li Y, Liu Q (2018) Value of combined detection of serum carcino-embryonic antigen, carbohydrate antigen 19\u20139 and cyclooxygenase-2 in the diagnosis of colorectal cancer. Oncol Lett 16(2):1551\u20131556","journal-title":"Oncol Lett"},{"issue":"3","key":"4098_CR95","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.21873\/anticanres.11430","volume":"37","author":"M Yoshikawa","year":"2017","unstructured":"Yoshikawa M, Morine Y, Ikemoto T, Imura S, Higashijima J, Iwahashi S et al (2017) Elevated preoperative serum CEA level is associated with poor prognosis in patients with hepatocellular carcinoma through the epithelial-mesenchymal transition. Anticancer Res 37(3):1169\u20131175","journal-title":"Anticancer Res"},{"issue":"1","key":"4098_CR96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2105-7-85","volume":"7","author":"JS Yuan","year":"2006","unstructured":"Yuan JS, Reed A, Chen F, Stewart CN (2006) Statistical analysis of real-time PCR data. BMC Bioinformatics 7(1):85","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"4098_CR97","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biocel.2010.03.017","volume":"42","author":"JW Yuen","year":"2010","unstructured":"Yuen JW, Poon LS, Chan AS, Yu FW, Lo RK, Wong YH (2010) Activation of STAT3 by specific Galpha subunits and multiple Gbetagamma dimers. Int J Biochem Cell Biol 42(6):1052\u20131059","journal-title":"Int J Biochem Cell Biol"},{"key":"4098_CR98","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2023.09.006","volume":"208","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Jiang H, Zhang X, Xu J, Wu X, Xu Q et al (2023) Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation. Free Radical Biol Med 208:571\u2013586","journal-title":"Free Radical Biol Med"},{"key":"4098_CR99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ceb.2019.07.006","volume":"61","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhou D (2019) Role of the transcriptional coactivators YAP\/TAZ in liver cancer. Curr Opin Cell Biol 61:64\u201371","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"4098_CR100","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.3892\/ol.2016.5291","volume":"12","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Yang J, Wang J (2016) Modulatory effect of luteolin on redox homeostasis and inflammatory cytokines in a mouse model of liver cancer. Oncol Lett 12(6):4767\u20134772","journal-title":"Oncol Lett"},{"issue":"21","key":"4098_CR101","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21(21):2747\u20132761","journal-title":"Genes Dev"},{"issue":"10","key":"4098_CR102","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/biom9100620","volume":"9","author":"L Zhou","year":"2019","unstructured":"Zhou L, Wang Q, Zhang H, Li Y, Xie S, Xu M (2019) YAP inhibition by nuciferine via AMPK-mediated downregulation of HMGCR sensitizes pancreatic cancer cells to gemcitabine. Biomolecules 9(10):620","journal-title":"Biomolecules"},{"key":"4098_CR103","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110821","volume":"132","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhu J, Yu S-J, Ma H-L, Chen J, Ding X-F et al (2020) Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK\/mTOR pathway. Biomed Pharmacother 132:110821","journal-title":"Biomed Pharmacother"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04098-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:13:06Z","timestamp":1761304386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4098"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04098-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}